Messner & Smith Theme Value Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$878K Sell
9,846
-670
-6% -$64.3K 1.46% 27
2017
Q4
$1.1M Buy
10,516
+7,069
+205% +$798K 1.75% 23
2017
Q3
$503K Sell
3,447
-70
-2% -$9.54K 0.79% 41
2017
Q2
$457K Hold
3,517
0.8% 46
2017
Q1
$438K Sell
3,517
-30
-0.8% -$3.59K 0.71% 43
2016
Q4
$411K Sell
3,547
-135
-4% -$15K 0.67% 48
2016
Q3
$385K Sell
3,682
-410
-10% -$44.4K 0.62% 50
2016
Q2
$404K Hold
4,092
0.74% 42
2016
Q1
$410K Sell
4,092
-3,493
-46% -$360K 0.81% 38
2015
Q4
$529K Buy
7,585
+4,385
+137% +$507K 0.85% 35
2015
Q3
$5K Sell
3,200
-3,759
-54% -$466K 0.01% 68
2015
Q2
$442K Buy
6,959
+15
+0.2% +$1.72K 0.61% 39
2015
Q1
$441K Buy
+6,944
New +$830K 0.63% 39

Other funds holding CELG

Messner & Smith Theme Value Investment Management's CELG Position: Q1 2018 in Review

Messner & Smith Theme Value Investment Management reduced its Celgene Corp (CELG) stake by 6.4% in Q1 2018, selling an estimated $64.3K and leaving 9,846 shares worth $878K. The position accounts for 1.46% of the portfolio, ranked #27.

Messner & Smith Theme Value Investment Management first reported a position in CELG in Q1 2015 and has held it in 13 quarters since. The position peaked at $1.1M in Q4 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Messner & Smith Theme Value Investment Management held 9,846 shares of Celgene Corp worth $878K as of Q1 2018.
  • Messner & Smith Theme Value Investment Management sold 670 Celgene Corp shares in Q1 2018, an estimated $64.3K.
  • Celgene Corp made up 1.46% of Messner & Smith Theme Value Investment Management's portfolio in Q1 2018, its #27 holding.
  • Messner & Smith Theme Value Investment Management first reported a position in Celgene Corp in Q1 2015 and has held it in 13 quarters since.
  • Messner & Smith Theme Value Investment Management's Celgene Corp position peaked at $1.1M in Q4 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Messner & Smith Theme Value Investment Management's 13F filing for Q1 2018, filed 9 May 2018.